For this reason, our analysis could more accurately represent the entire heterogeneity of the tumor compared to tissue biopsy, explaining the detection of the IDH1 mutation in the cfDNA of a subgroup of patients negative on tissue. This evidence concerns the gene IDH1 and neoplasm.